Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis

Clinical trial NCT07137819 · RECRUITING

Trial details

NCT number: NCT07137819
Sponsor: Aresus Pharma GmbH
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis of Face and Scalp

Start date: 2024-09-04
Primary completion: 2026-03-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.